Premium
Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: All that is gold does not glitter, not all those who wander are lost
Author(s) -
Musso Giovanni
Publication year - 2015
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27772
Subject(s) - obeticholic acid , medicine , farnesoid x receptor , nonalcoholic fatty liver disease , gastroenterology , placebo , fatty liver , chronic liver disease , cirrhosis , liver disease , liver biopsy , disease , pathology , biopsy , agonist , receptor , biochemistry , chemistry , alternative medicine , nuclear receptor , transcription factor , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom